RACGAP1P1 and breast cancer: Our results demonstrated that the up‐regulation of RACGAP1P was a commonly oncogenic event in breast cancer, which is correlated with lymph node metastasis, distance metastasis, TNM stage, and poor prognosis of breast cancer patients.